Technetium-99m (V) DMSA uptake in amyloidosis.
Technetium-99m(V) DMSA scintigraphy was performed in two patients with pathologically confirmed amyloidosis associated with plasmacytoma. Significant uptake of the tracer was found in the deposition of amyloid. Technetium-99m(V) DMSA scintigraphy could be useful in determining the appropriate region of biopsy and in forecasting the prognosis of patient with plasmacytoma.
Ohta
H
H
Department of Nuclear Medicine, Kyoto University School of Medicine, Japan.
Endo
K
K
Kanoh
T
T
Konishi
J
J
Kotoura
H
H
D000368:Aged; D000369:Aged, 80 and over; D000686:Amyloidosis / Q000150:complications / Q000000981:diagnostic imaging* / Q000378:metabolism; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000150:complications / Q000000981:diagnostic imaging; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics*; D010255:Paranasal Sinus Neoplasms / Q000150:complications / Q000000981:diagnostic imaging; D010954:Plasmacytoma / Q000150:complications / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D004113:Succimer / Q000493:pharmacokinetics*; D013438:Sulfhydryl Compounds / Q000493:pharmacokinetics*; D019783:Technetium Tc 99m Dimercaptosuccinic Acid
D015609:Organotechnetium Compounds; D013438:Sulfhydryl Compounds; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D004113:Succimer